Daniel Vitt, CEO, Immunic Therapeutics, discusses promising results from the Phase Ib trial of IMU-856 in celiac disease.
High potency complete formula including methyl B12, the active form of B12 ... Women take 1 tablet daily, preferably with food. Gluten-free. No artificial colors.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback